Shape TherapeuticsÕ next-generation gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Founded by Francois Vigneault, John Suliman, and Prashant Mali in 2018, Shape Therapeutics is backed by investors that include CureDuchenne Ventures and New Enterprise Associates and is headquartered in Seattle.